Indeed, circFOXK2 enhances glucose transporter 1 (GLUT1) stability via IGF2BP3 in a m6A-dependent manner, thereby promoting cancer cells aerobic glycolysis [108]. This evidence concerns the gene SLC2A1 and cancer.